clinical-feasibility-assessor

What problem does it solve?

It helps you evaluate whether a drug candidate for Oral Mucositis (OM) can realistically progress from early development to actually reaching patients, considering regulation, timelines, costs, manufacturing, and real-world viability.

Core Features & Use Cases

• Regulatory pathway selection: Matches likely FDA/EMA/AYUSH-type routes (e.g., NDA, 505(b)(2), DSHEA, device pathways) to the candidate’s nature (repurposed drug, natural extract, topical formulation).
• Development cost and timeline estimating: Provides stage-based cost and duration ranges (preclinical through manufacturing/regulatory) and adjusts for OM-specific factors like topical vs systemic scope.
• Feasibility checks across formulation, trials, commercial viability, and manufacturing: Flags common bottlenecks such as stability, GMP supply chain constraints, endpoint clarity, recruitment challenges, and IP risk.
• Actionable decision output: Produces a structured assessment with go/no-go recommendation, top risks with mitigations, and a key de-risking next step.

Quick Start

Use the clinical-feasibility-assessor skill to generate an end-to-end feasibility report for the OM repurposing candidate you want to advance, including regulatory route, estimated timeline, cost range, trial design considerations, manufacturing risks, and a Go/No-Go recommendation.